The US NIH has initiated a clinical trial for remdesivir and two pharmaceutical companies will work together to manufacture antibody treatments to tackle the coronavirus.

Join our upcoming webinar which will guide you through efficiency gains with TOC for cleaning validation. We call it a ‘beginner’s guide’, but this webinar will benefit long-time TOC users as well as those new to using TOC for cleaning validation.

A statement by the Takeda reveals the company has acquired PvP as part of a development and option agreement for the drug TAK-062.

NICE has formed a negative opinion for Polivy (polatuzumab vedotin) in combination with rituximab and bendamustine to treat diffuse large B-cell lymphoma.

Researchers have shown that the CALB lipase enzyme can be used to produce macrocycles of a specified shape using biocatalysis.